Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

There are many people with online courses and cure-all products to sell you to help with stress. That said, is "cortisol ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Andy and Anna Mignery share their health journey by providing clean eating choices at The Thrivery in Center Point.

Type 2 diabetes is a global health concern, especially in low- and middle-income countries, where its prevalence is rapidly increasing ...

Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by ...

Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are ...

Salivary cortisol measurements are particularly useful to investigate cyclical Cushing's syndrome. At least partial autonomy of cortisol production (either direct from the adrenal cortex or ...